Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Recurrence × pomalidomide × Clear all

Status

Completed 17 Recruiting 8 Active not recruiting 8 Terminated 6 Unknown 3 Withdrawn 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Multiple Myeloma 1

Interventions

ibrutinib 2 vorasidenib 1 talquetamab 1 pomalidomide 1 fludarabine 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Cyclophosphamide 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01632826 2019-11-12

PEXIUS

Celgene

Approved for marketing

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡